AbCellera Biologics ABCL
NASDAQ ABCL
$13.92 +1.22 (+9.61%)
At close: Sep 28, 2026 · 4:00 PM EDT

AbCellera Biologics (ABCL) Net Preferred Shares Issued and Repurchased (2020)

Updated

AbCellera Biologics (ABCL) reported Net Preferred Shares Issued and Repurchased of -$1,000 for Q4 2020.

Analysis

AbCellera Biologics (ABCL) Net Preferred Shares Issued and Repurchased (2020) Analysis & Trends

For FY2020, AbCellera Biologics posted Net Preferred Shares Issued and Repurchased of $74.66 million.

  • By year, Net Preferred Shares Issued and Repurchased came in at -$11,000 in FY2019.
  • Five-year quarterly Net Preferred Shares Issued and Repurchased spans a low of -$19,000 in Q3 2020 and a high of $74.66 million in Q1 2020.
  • Per Business Quant data, the three quarters before Q4 2020 came in at -$19,000 (Q3 2020), $20,000 (Q2 2020) and $74.66 million (Q1 2020).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Johnson & Johnson 653.54 Bn 572.07 Bn 17.26 Bn -
2 AbbVie 467.01 Bn 440.17 Bn 12.70 Bn -
3 Merck 367.16 Bn 321.59 Bn 12.21 Bn -
4 Novartis Ag 277.56 Bn 233.43 Bn 11.24 Bn -
5 Astrazeneca 258.23 Bn 231.79 Bn 12.86 Bn -
6 Amgen 224.14 Bn 179.54 Bn 7.24 Bn -
7 Gilead Sciences 187.30 Bn 161.42 Bn 6.22 Bn -
8 Pfizer 163.47 Bn 110.41 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.31 Bn 105.31 Bn 2.84 Bn -
10 AbCellera Biologics 3.89 Bn 3.89 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2020 -1,000.00
Sep 30, 2020 -19,000.00
Jun 30, 2020 20,000.00
Mar 31, 2020 74.66 Mn
API Access

AbCellera Biologics Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ABCL&period=max&api_key=YOUR_API_KEY